# Primary Lymphedema and Mutation CELSR1 (Cadherin EGF LAG Seven-pass G-type Receptor 1)

> **NCT04919655** · — · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 31 (estimated)

## Conditions studied

- Primary Lymphedema

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04919655
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-02-20
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2021-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04919655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04919655, "Primary Lymphedema and Mutation CELSR1 (Cadherin EGF LAG Seven-pass G-type Receptor 1)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04919655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*